The global enteral feeding formulas market was valued at 0.00 in 2024 driven by the rising aging population and prevalence of chronic diseases across the globe. It is further projected to grow at a CAGR of 0.00% during 2025-2034, reaching 0.00 in 2034.
Base Year
Historical Period
Forecast Period
The market is expected to expand as the global aging population increases, driving demand for nutritional support for individuals with chronic conditions and age-related diseases.
Technological advancements in enteral feeding formulas, such as improved taste, digestibility, and nutrient composition, are expected to drive market growth, offering more tailored solutions for patients' unique needs.
With rising awareness of malnutrition and increased hospitalization rates, the enteral feeding formulas market will see steady growth, supported by rising healthcare expenditure and improved access to medical nutrition.
Value in
2025-2034
Enteral Feeding Formulas Market Outlook
*this image is indicative*
Enteral feeding formulas are liquid or powdered nutritional products designed for individuals who cannot consume food orally but still have a functional digestive system. These formulas are administered through a feeding tube directly into the stomach or intestines. They provide essential nutrients, including carbohydrates, proteins, fats, vitamins, and minerals, tailored to meet the specific needs of patients, such as those with chronic illnesses, malnutrition, or difficulty swallowing. Enteral feeding ensures proper nutrition when oral intake is not possible, supporting recovery and maintaining health. Different formulas cater to various conditions, including diabetes, renal disease, or critical illness.
Innovation in Enteral Feeding Formulas to Boost Market Growth and Development
Rising demand for more personalised and effective enteral nutrition solutions, coupled with technological advancements in medical devices, is driving the growth of the enteral feeding formulas market. For instance, in September 2024, EN Otsuka Pharmaceutical Co., Ltd. received marketing approval for its semi-solid enteral nutrition formula, "ENOSOLID® Semi Solid for Enteral Use." This formula is designed for patients requiring less maintenance energy and provides balanced nutrients in line with the typical Japanese diet. The formula’s ability to offer 900 kcal and targeted volumes of vitamins and trace elements makes it an ideal option for patients with specific energy needs. As the clinical demand for more accessible, easily digestible nutrition products continues to rise, this approval signifies a critical step in meeting the nutritional needs of these patients. This innovation will likely accelerate market growth by broadening product offerings and driving adoption of semi-solid formulations, aligning with evolving clinical practices.
Surge in FDA Approvals to Meet Growing Enteral Feeding Formulas Market Demand
The increasing prevalence of malabsorption issues, such as those found in short bowel syndrome (SBS), is driving innovation in enteral nutrition devices. For instance, in December 2023, Alcresta Therapeutics, Inc. announced the 510(k) clearance of its next-generation RELiZORB® cartridge by the U.S. FDA. This device, designed to break down fats in enteral formula, has been expanded to accommodate a wider variety of nutrition formulas, including those commonly used for SBS patients. The updated device allows for both continuous and bolus feeding, supporting up to six cartridges per day, thus expanding the range of patients who can benefit. This innovation addresses a critical need in the clinical nutrition space, enabling more patients to receive effective nutritional support. As the next-generation RELiZORB becomes more widely available, it will significantly impact the growth of the enteral feeding formulas market by enhancing the effectiveness and versatility of enteral feeding solutions, particularly for patients with complex digestive conditions.
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
Enteral Feeding Formulas Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Product
Market Breakup by Stage
Market Breakup by Application
Market Breakup by End User
Market Breakup by Distribution Channel
Market Breakup by Region
Standard Formulas to Lead the Segmentation by Product
The standard formula segment likely holds the largest market share due to its broad applicability for general nutritional support. These formulas are widely used for patients with varying needs, including those recovering from surgery or dealing with chronic conditions. The ease of use and the ability to cater to a wide range of nutritional deficiencies make standard formulas highly popular. With the increasing prevalence of malnutrition, ageing populations, and long-term care needs, this segment is poised for continued growth, driving the overall market forward in the forecast period.
Pediatrics to Hold a Significant Enteral Feeding Formulas Market Value for Segmentation by Stage
The pediatrics stage may lead the market due to the rising demand for specialised nutrition in children with developmental, nutritional, or medical challenges. Paediatric enteral feeding formulas are formulated to meet the specific needs of infants and young children, providing the right balance of nutrients for growth and development. Increasing awareness of paediatric malnutrition and medical conditions such as premature birth, metabolic disorders, and gastrointestinal issues is driving the demand. As healthcare systems focus more on childhood health and nutrition, the paediatric segment will continue to dominate and drive future market growth.
Oncology to Lead the Share by Application
Oncology is poised to be the leading application segment driven by the growing need for nutritional support in cancer patients. Cancer treatments often lead to significant weight loss, malnutrition, and difficulty in eating, which increases the demand for enteral feeding solutions. These formulas help maintain nutritional levels, support recovery, and improve the quality of life for cancer patients. With the global rise in cancer cases and increasing awareness of the role of nutrition in treatment, the oncology application segment is set for substantial growth, driving the overall market forward in the coming years.
Hospitals to Dominate the Enteral Feeding Formulas Market Segmentation by End User
Hospitals will likely hold the largest share in the market by end user due to their central role in providing critical care and long-term medical support to patients. Hospital settings require enteral feeding formulas for patients with a variety of conditions, including those in intensive care, post-surgery, or with chronic illnesses. The growing incidence of hospitalisation, coupled with an increasing emphasis on clinical nutrition, ensures that hospitals will continue to be the dominant end user. This segment will drive market growth in the forecast period, supported by advancements in healthcare infrastructure and medical technology.
Hospital Pharmacies to Lead the Enteral Feeding Formulas Market by Distribution Channel
Hospital pharmacies are projected to dominate the distribution channel segment in the market, owing to the high volume of feeding formulas required for patients undergoing medical treatment. These pharmacies are the primary distributors for hospital-based enteral nutrition, ensuring that patients receive timely and appropriate nutritional support. The increasing hospitalisation rates, coupled with the growing emphasis on medical nutrition therapy, make hospital pharmacies a crucial distribution channel. With the expanding healthcare sector and rising demand for enteral feeding, hospital pharmacies are set to continue driving the market's growth in the forecast period.
Enteral Feeding Formulas Market Analysis by Region
North America is likely to hold the largest market share, driven by its advanced healthcare infrastructure and high prevalence of chronic diseases. The region's robust healthcare system supports extensive use of enteral feeding formulas, especially in hospitals and long-term care facilities. Additionally, the increasing ageing population and the growing demand for specialised nutrition for conditions like cancer, diabetes, and neurological disorders contribute to the market's growth. The presence of key market players in the U.S. and Canada, combined with strong research and development activities, further strengthens North America's dominance. As healthcare costs rise and medical nutrition becomes a priority, North America's market share is set to expand.
The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Headquartered in Paris, France, Danone S.A. was established in 1919 and is a global leader in the food and beverage sector, with a strong presence in the enteral feeding formulas market. The company offers a broad range of nutritional products, including specialised enteral formulas under its medical nutrition division. Danone’s portfolio includes brands such as Nutricia, which provides products designed for individuals with specific health needs, such as Paediatrics, oncology, and critical care. Danone’s focus on innovation and nutritional science ensures high-quality products that support patients' recovery and overall well-being, particularly in managing malnutrition.
Founded in 1867 and headquartered in Vevey, Switzerland, Nestlé S.A. is one of the world's largest food and beverage companies, with a strong foothold in the global enteral feeding formulas market. Nestlé offers a comprehensive range of enteral feeding products under its healthcare nutrition division, including specialised formulas for managing health conditions such as diabetes, cancer, and gastrointestinal issues. Brands like Peptamen and Impact provide tailored solutions for patients in hospitals, long-term care facilities, and home care settings. Nestlé’s commitment to scientific research and nutritional innovation plays a vital role in enhancing patient care through its enteral nutrition offerings.
Abbott, established in 1888 and headquartered in Abbott Park, Illinois, USA, is a leading global healthcare company, renowned for its advancements in medical devices, diagnostics, and nutritional products. In the enteral feeding formulas market, Abbott offers a wide range of products designed to meet the nutritional needs of patients with various conditions, including Ensure, a well-known brand offering complete nutrition. Abbott’s enteral nutrition products are widely used in hospitals, home care, and long-term care settings. The company’s ongoing focus on innovation and its commitment to patient-centred care position it as a significant player in the global enteral feeding formulas market.
Mead Johnson & Company, established in 1905 and headquartered in Glenview, Illinois, USA, is a leading player in the global nutritional products market, particularly in the field of enteral feeding formulas. Known for its Enfamil brand, Mead Johnson provides specialised nutritional formulas that support infant and paediatric care, as well as products designed for adult patients with specific dietary needs. The company’s enteral formulas cater to conditions such as malnutrition, metabolic disorders, and chronic illness, with a focus on providing tailored nutritional support to enhance recovery and overall health. Mead Johnson’s commitment to scientific research ensures high-quality, effective products.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Fresenius Kabi AG, B. Braun SE, Otsuka Pharmaceutical Co., Ltd., Kate Farms, Meiji Holdings Co., Ltd., and Nutritional Medicinals, LLC.
Enteral Feeding Formulas Market Size
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
In 2024, the global enteral feeding formulas market attained a value of nearly USD 8.14 billion.
The market is projected to grow at a CAGR of 7.1% between 2025 and 2034.
The market is estimated to witness a healthy growth in the forecast period of 2025-2034 to reach about USD 15.22 billion by 2034.
The market is being driven by surging demand for enteral feeding formulas by patients affected from chronic diseases like cancer, cardiovascular disorders, and kidney diseases, among others.
Robust research and development and the corresponding development of new products to cater the increasing demand for enteral feeding formulas are pushing the growth of the market.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The major products of enteral feeding formulas are standard formula and disease specific formulas.
The various flow types of enteral feeding formulas are intermittent feeding flow and continuous feeding flow.
The several stages of enteral feeding formulas are adults and paediatrics.
The major indications of enteral feeding formulas are Alzheimer’s, nutrition deficiency, cancer care, diabetes, chronic kidney diseases, orphan diseases, dysphagia, pain management, and malabsorption/GI disorder, and diarrhoea, among others.
The significant end users of enteral feeding formulas are hospitals and home care.
The major players in the industry are Danone S.A., Nestlé S.A., Abbott Nutrition, Mead Johnson & Company, LLC, and Fresenius Kabi AG, among others.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2024 |
| Historical Period | 2018-2024 |
| Forecast Period | 2025-2034 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Stage |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share